Get started
Author

Alexander Karachunskiy

Observed names: A I KARACHUNSKIY, A. I. Karachunskiy, A. I. Karachunsky, A. Karachunskiy, A. Karachunsky, A.I. Karachunskiy, A.I. Karachunsky, Alexander I Karachunskiy, Alexander I. Karachunsky, Alexander Karachunsky, А. I. Karachunsky, А.I. Karachunskiy
ORCID: 0000-0002-9300-5198
Observed ORCID: 0000-0002-9300-5198
OpenAlex ID: A5114021996
Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia
2019 · Alexander Popov, Guenter Henze, et al. · Journal of Cancer Research and Clinical Oncology · 44
657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls
2003 · Igor B. Resnick, Irina Kondratenko, et al. · American Journal of Medical Genetics Part A · 36
Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
2022 · Ekaterina Mikhailova, Olga Illarionova, et al. · Cancers · 25
PDF
Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies
2023 · A. M. Popov, T. Yu. Verzhbitskaya, et al. · Pediatric Hematology/Oncology and Immunopathology · 24
PDF
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
2022 · Alexander Popov, Guenter Henze, et al. · Leukemia · 18
Molecular heterogeneity of pediatric choroid plexus carcinomas determines the distinctions in clinical course and prognosis
2022 · Margarita Zaytseva, Andge Valiakhmetova, et al. · Neuro-Oncology · 17
B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting
2022 · Ekaterina Mikhailova, Albert Itov, et al. · Cytometry Part B Clinical Cytometry · 17
Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy
2020 · Andge Valiakhmetova, Ludmila Papusha, et al. · Pediatric Blood & Cancer · 16
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols
2020 · Alexander Popov, Barbara Buldini, et al. · Leukemia · 16
Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL
2024 · Ekaterina Mikhailova, Alexander Popov, et al. · Journal for ImmunoTherapy of Cancer · 15
The experience of successful treatment of ETV6-NTRK3-positive infant glioblastoma with entrectinib
2021 · Ludmila Papusha, Margarita Zaytseva, et al. · Neuro-Oncology Advances · 15
PDF
The influence of a dosage regimen of dexamethasone on detection of normal B-cell precursors in the bone marrow of children with BCP-ALL at the end of induction therapy
2020 · E. V. Mikhailova, T. Yu. Verzhbitskaya, et al. · Pediatric Hematology/Oncology and Immunopathology · 15
PDF
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study
2022 · Alexander Popov, Guenter Henze, et al. · Journal of Cancer Research and Clinical Oncology · 14
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement
2023 · Alexander Popov, Guenter Henze, et al. · Pediatric Blood & Cancer · 12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol
2023 · Alexander Popov, Grigory Tsaur, et al. · Pediatric Blood & Cancer · 12
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements
2021 · Alexander Popov, Grigory Tsaur, et al. · British Journal of Haematology · 12
Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol
2021 · Grigory Tsaur, Alexander Popov, et al. · British Journal of Haematology · 11
PDF
Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies
2023 · A. M. Popov, E. V. Mikhailova, et al. · Pediatric Hematology/Oncology and Immunopathology · 9
PDF
Strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in children
2021 · Ekaterina Mikhailova, Julia Roumiantseva, et al. · British Journal of Haematology · 9
PDF
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial
2023 · Larisa Fechina, Alexander Popov, et al. · Leukemia · 8
Guidelines for the flow cytometric minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia after CD19-directed immunotherapy
2023 · E. V. Mikhailova, O. I. Illarionova, et al. · Pediatric Hematology/Oncology and Immunopathology · 8
PDF
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
2022 · Alexander Popov, Guenter Henze, et al. · Leukemia Research · 8
Magnetic resonance imaging of changes in the brain of children cured of acute lymphoblastic leukemia
2019 · Vladislav P. Bondarenko, Galina V. Tereschenko, et al. · Hematology Reports · 8
PDF
Contribution of All-Trans Retinoic Acid to Improved Early Relapse-Free Outcome in Infant Acute Lymphoblastic Leukemia Comparing to the Chemotherapy Alone.
2007 · Larisa Fechina, Egor Shorikov, et al. · Blood · 8
Midline Low-Grade Gliomas of Early Childhood: Focus on Targeted Therapies
2024 · Ludmila Papusha, Margarita Zaytseva, et al. · JCO Precision Oncology · 6
Works count: 104
Citation count: 528
H-index: 13
I10-index: 17
Year
Topic
Type